Renowned leader in the field of liver disease takes on new role leading advocacy and research.
Doylestown, PA, February 13, 2014 --(PR.com)--
The Hepatitis B Foundation (www.hepb.org), the only national nonprofit
organization solely dedicated to finding a cure for hepatitis B, is
pleased to announce that Robert G. Gish, M.D., became the foundation’s
medical director on Jan. 30, 2014.
An internationally renowned
medical researcher in the field of viral hepatitis, Dr. Gish has made
invaluable contributions to the understanding and treatment of hepatitis
B, which is the world’s leading cause of liver cancer. A longtime
supporter of the foundation’s mission and a member of the Scientific
Advisory Board, Dr. Gish’s new role will further strengthen its research
and advocacy efforts worldwide.
“We are delighted to welcome Dr.
Gish to our board,” said Dr. W. Thomas London, senior member emeritus
of Fox Chase Cancer Center and vice president of the board of directors
of the Hepatitis B Foundation. “He has long been a leader in the field
and has extensive experience in the conduct of clinical trials of new
drugs to combat chronic hepatitis B. His leadership as medical director
will help us advance the treatment and prevent the severe consequences
of this potentially deadly disease.”
Labels: Gish, HBV